Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Current oncology (Toronto, Ont.)·2026
Same author

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

Medicina (Kaunas, Lithuania)·2026
Same author

Driveline Infections in Durable LVAD Support: Risk Factors, Microbiology, and Resistance Patterns from a Large Cohort.

Diagnostics (Basel, Switzerland)·2026
Same author

Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Stenotrophomonas maltophilia infections in intensive care units: a prospective and international ID-IRI study.

Journal of infection in developing countries·2026
Same author

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Cancers·2026

Related Experiment Video

Updated: Jul 9, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Current Vaccination Principles and Practices in Adult Cancer Patients.

Dilşah Başkol Elik1, Esra Erdem Kıvrak2, Hasan Çağrı Yıldırım3

  • 1Department of Infectious Diseases and Clinical Microbiology, Turgutlu State Hospital, Manisa, Türkiye.

Journal of Clinical Practice and Research
|July 8, 2026
PubMed
Summary
This summary is machine-generated.

Adult cancer patients face high infection risks. Vaccinations, especially inactivated and recombinant types, are safe and beneficial, reducing severe infections and hospitalizations when given strategically.

Keywords:
Adult cancer patientsimmunizationimmunosuppressionpreventive carevaccination

Related Experiment Videos

Last Updated: Jul 9, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • Cancer patients experience increased infectious complications due to immune dysregulation and cancer treatments.
  • Vaccine-preventable infections pose significant risks, causing morbidity and mortality in this population.
  • Current vaccination strategies for adult solid tumor patients require comprehensive review.

Purpose of the Study:

  • To review current evidence on vaccination strategies for adult patients with solid tumors.
  • To summarize international guideline recommendations for vaccinating cancer patients.
  • To provide guidance on optimizing vaccine efficacy and safety in oncology care.

Main Methods:

  • Systematic review of current evidence and international guidelines.
  • Analysis of vaccination safety and efficacy data in adult cancer patients.
  • Evaluation of recommendations for inactivated, recombinant, and live attenuated vaccines.

Main Results:

  • Inactivated and recombinant vaccines are generally safe and effective, ideally administered before immunosuppressive therapy.
  • While immune responses may be reduced during treatment, vaccinations offer clinical benefits against severe infections and hospitalizations.
  • Live attenuated vaccines are contraindicated in significant immunosuppression and require immune reconstitution for consideration.

Conclusions:

  • Proactive, guideline-based vaccination should be integrated into routine oncology care.
  • Individualized scheduling and consideration of treatment-related immune effects are crucial for optimizing outcomes.
  • Vaccinating household contacts is also recommended to protect vulnerable cancer patients.